Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Vivos (RDGL) Short-Term Debt issuances (2010 - 2015)

Vivos recorded quarterly Short-Term Debt issuances of -$423000.0 in Q4 2015, down 220.89% quarter-over-quarter from $349913.0 in Q4 2014, and down 220.89% year-over-year from $349913.0 in Q4 2014.

Vivos' Short-Term Debt issuances history runs 6 years deep, the most recent figure standing at -$423000.0 for Q4 2015.

  • In Q4 2015, Short-Term Debt issuances fell 220.89% year-over-year to -$423000.0; the TTM figure through Dec 2015 stood at -$73087.0 (down 110.44% YoY), while the FY2015 annual figure was -$255000.0, changed N/A from the prior year.
  • Short-Term Debt issuances came in at -$423000.0 for Q4 2015 at Vivos, down from $349913.0 in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $349913.0 in Q2 2013 to a low of -$423000.0 in Q4 2015.
  • A 5-year average of $49758.4 and a median of $55000.0 in 2011 frame the typical range for Short-Term Debt issuances.
  • Across the five-year window, Short-Term Debt issuances soared 483.19% in 2013 and tumbled 220.89% in 2015, its largest moves.
  • Vivos' Short-Term Debt issuances stood at $171000.0 in 2011, then slumped by 161.4% to -$105000.0 in 2012, then soared by 433.25% to $349913.0 in 2013, then changed by 0.0% to $349913.0 in 2014, then sank by 220.89% to -$423000.0 in 2015.
  • According to Business Quant data, Short-Term Debt issuances over the past three periods registered -$423000.0, $349913.0, and $349913.0 for Q4 2015, Q4 2014, and Q2 2013 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 31.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -1.23 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -1.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 37.80 Mn
10 Vivos - - -3,105.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2015 -423,000.00
Dec 31, 2015 -423,000.00
Dec 31, 2014 349,913.00
Dec 31, 2014 349,913.00
Jun 30, 2013 349,913.00
Jun 30, 2013 349,913.00
Dec 31, 2012 -105,000.00
Dec 31, 2012 -105,000.00
Jun 30, 2012 60,000.00
Jun 30, 2012 60,000.00
Mar 31, 2012 45,000.00
Mar 31, 2012 45,000.00
Dec 31, 2011 171,000.00
Dec 31, 2011 171,000.00
Sep 30, 2011 -55,000.00
Sep 30, 2011 -55,000.00
Jun 30, 2011 55,000.00
Jun 30, 2011 55,000.00
Sep 30, 2010 60,000.00
Sep 30, 2010 60,000.00